Resumen de acción MCK
McKesson Corporation presta servicios sanitarios en Estados Unidos y a escala internacional.
| Puntuación del copo de nieve | |
|---|---|
| Valoración | 5/6 |
| Crecimiento futuro | 3/6 |
| Resultados anteriores | 2/6 |
| Salud financiera | 2/6 |
| Dividendos | 0/6 |
Competidores de McKesson Corporation
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$578.43 |
| Máximo en 52 semanas | US$612.17 |
| Mínimo de 52 semanas | US$395.30 |
| Beta | 0.45 |
| 11 mes Cambio | -4.06% |
| Variación en 3 meses | 10.21% |
| Cambio de 1 año | 38.13% |
| 3Variación en 3 años | 190.62% |
| Variación en 5 años | 318.79% |
| Variación desde la OPV | 3,405.64% |
Noticias y actualizaciones recientes
Recent updates
McKesson Corporation: An Interesting Health Giant With A Hidden Gem
Jul 04With McKesson Corporation (NYSE:MCK) It Looks Like You'll Get What You Pay For
May 09
Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?
Mar 14McKesson: GLP-1 Contributed More Than 1/3 Of Growth
Feb 19McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues
Feb 16Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking
Jan 29McKesson: Why The Company Is Too Richly Valued
Jan 19If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity
Nov 20McKesson: GLP-1 Medications Tailwinds And Massive Share Repurchase
Nov 08Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?
Oct 30McKesson: Still Trading For A Huge Discount
Sep 06Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors
Aug 21Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?
Jul 27McKesson: Outlook Remains Positive, I Reiterate My Buy Recommendation
Jun 28Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors
May 23Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?
Apr 17Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?
Feb 22McKesson Corporation: Looking Forward To Long-Term Low-Teens EPS Growth
Feb 08McKesson Non-GAAP EPS of $6.90 beats by $0.54, revenue of $70.5B misses by $480M
Feb 01McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price
Jan 125 Reasons Why I Am Considering Adding McKesson To My Portfolio
Dec 27McKesson Corporation: Still Trading Below Intrinsic Value
Dec 13Duration: The Time Bomb In Your Portfolio - McKesson And PayPal In Focus
Oct 08McKesson extends distribution partnership with CVS Health
Sep 29An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 50% Undervalued
Sep 19McKesson to acquire Rx Savings Solutions in $875M deal
Sep 19Cardinal Health, McKesson hit 52-week highs; up 35% and 50% YTD
Aug 15McKesson raises fiscal 2023 adjusted diluted EPS following strong quarterly results
Aug 03McKesson raises dividend by 15% to $0.54/share
Jul 25McKesson Is Still An Attractive Dividend Growth Stock
Jul 10Rentabilidad de los accionistas
| MCK | US Healthcare | Mercado US | |
|---|---|---|---|
| 7D | 0.6% | 5.3% | -0.7% |
| 1Y | 38.1% | 4.3% | 20.2% |
Rentabilidad vs. Industria: MCK superó a la industria US Healthcare, que obtuvo un rendimiento del 3.5% el año pasado.
Rentabilidad vs. Mercado: MCK superó al mercado US, que obtuvo un rendimiento del 22.3% el año pasado.
Volatilidad de los precios
| MCK volatility | |
|---|---|
| MCK Average Weekly Movement | 2.1% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 2.9% |
Precio estable de las acciones: MCK no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de MCK (2%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1833 | 48,000 | Brian Tyler | www.mckesson.com |
McKesson Corporation presta servicios sanitarios en Estados Unidos y a escala internacional. Opera a través de cuatro segmentos: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions e Internacional.
Resumen de fundamentos de McKesson Corporation
| Estadísticas fundamentales de MCK | |
|---|---|
| Capitalización bursátil | US$75.50b |
| Beneficios(TTM) | US$3.00b |
| Ingresos (TTM) | US$308.95b |
25.0x
Ratio precio-beneficio (PE)0.2x
Ratio precio-ventas (PS)¿Está MCK sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de MCK | |
|---|---|
| Ingresos | US$308.95b |
| Coste de los ingresos | US$296.37b |
| Beneficio bruto | US$12.58b |
| Otros gastos | US$9.58b |
| Beneficios | US$3.00b |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
Aug 07, 2024
| Beneficios por acción (BPA) | 23.14 |
| Margen bruto | 4.07% |
| Margen de beneficio neto | 0.97% |
| Ratio deuda/patrimonio | -342.2% |
¿Cómo se ha desempeñado MCK a largo plazo?
Ver rendimiento histórico y comparativa